Health in Egypt

1,428 indicators covering health for Egypt.

IndicatorLatest Year10-yr change Rank
HIV-positive TB patients on ART (antiretroviral therapy) 100.0% 2024 unchanged 1st
Hospital beds 10.59 2021 down 24.5% 122nd
Treatment success rate for patients treated for MDR-TB 80.0% 2022 up 27.0% 50th
New leprosy case detection rate per 1 000 000 population 4.47 2024 down 33.9% 60th
Treatment success rate: HIV-positive TB cases 66 2023 up 127.6% 105th
Prevalence of wasting, weight for height 3.3% 2021 down 58.2% 60th
Estimated number of children (aged 0-17 years) who have lost one or 2.10 million 2024 up 10.5% 11th
Bladder cancer death rate 1.69 2019 down 46.7% 57th
Cancer death rates by type who db 1.69 2019 down 46.7% 57th
Weight-for-height <-2 SD 3.35 2021 down 57.9% 60th
Earthquake deaths 11 1995 13th
Sex ratio at birth 1.05 2024 up 0.5% 45th
Crude birth rate 20.91 2024 down 26.3% 8th
Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 98.0% 2025 16th
International Health Regulations core capacity scores, SPAR version 90 2025 14th
Prevalence of underweight, weight for age 3.7% 2021 down 45.6% 68th
Leprosy registered prevalence rate per 1 000 000 population 9.29 2024 up 43.9% 52nd
Leprosy - Number of new leprosy cases among children 64 2024 up 190.9% 16th
Leprosy - Number of cases registered for treatment 1,082 2024 up 101.1% 16th
New leprosy child case detection rate (less than 15 years of age) per 1.72 2024 up 132.8% 37th
GNI, Atlas method 408.68 billion 2024 up 39.8% 20th
GNI per capita, Atlas method 3,510 2024 up 17.0% 66th
Children (0-14) living with HIV 940 2024 up 27.0% 55th
Ipv1 number unvaccinated 46,530 2023 58th
Children living with hiv 940 2024 up 27.0% 55th
Contraceptive prevalence, any method 58.5% 2014 down 2.5% 52nd
Children (ages 0-14) newly infected with HIV 500 2024 up 150.0% 29th
Number of reported cases of poliomyelitis by wild poliovirus 0 2023 3rd
Age-standardized prevalence of current tobacco use among persons aged 25.0% 2024 up 10.6% 44th
Liver cancer death rate 9.96 2019 up 5.7% 5th
Refugees under the mandate of the UNHCR by country or territory of 238,014 2024 up 0.8% 16th
Number of children newly infected with hiv 500 2024 up 150.0% 29th
Share of children under fifteen years old with hiv 213.3 2024 up 55.4% 44th
Number of female leprosy new cases 245 2024 up 16.7% 18th
Estimated number of malaria deaths 0 2024 66th
Estimated number of malaria cases 0 2024 82nd
National smoking ban: NUMBER OF PLACES SMOKE-FREE 8 2022 unchanged 1st
Contraceptive prevalence, any modern method 56.9% 2014 up 0.5% 34th
Number of prevalent tuberculosis cases 23,000 2014 down 8.0% 53rd
Estimated malaria incidence 0 2024 82nd
Estimated malaria mortality rate 0 2024 66th
Number of new G2D leprosy cases 88 2024 up 87.2% 18th
Leprosy - New leprosy cases with G2D rate per 1 000 000 population 0.755 2024 up 47.5% 53rd
3.7.2 Adolescent birth rate per 1,000 women 47 2019 up 44.4% 73rd
Proportion of total government spending on essential services, health 5.0% 2015 up 14.9% 100th
3.1.2 Proportion of births attended by skilled health personnel 92 2014 up 32.6% 117th
Pancreatic cancer death rate 1.84 2019 up 35.4% 101st
Brain and nervous system cancer death rate 3.89 2019 down 22.1% 29th
Inflation-adjusted prices for most sold brand of cigarettes: Prices 4.4 2022 up 0.5% 123rd
Taxes as a % of price: total tax 74.9% 2022 up 3.3% 42nd
Taxes as a % of price: value added tax 0.0% 2022 177th
Taxes as a % of price: ad valorem excise 50.0% 2022 unchanged 12th
Taxes as a % of price: specific excise 19.5% 2022 down 6.3% 103rd
Taxes as a % of price: import duties 0.0% 2022 38th
Taxes as a % of price: other taxes 5.4% 2022 up 221.6% 15th
Lifetime risk of maternal death 0.045 2023 down 54.5% 15th
Inflation-adjusted prices for most sold brand of cigarettes: Price in 20.5 2022 up 16.5% 108th
Estimated number of children needing antiretroviral therapy based on 990 2025 up 28.6% 57th
Weight-for-height <-3 SD 1.47 2021 down 61.1% 31st
Prevalence of severe wasting, weight for height 1.5% 2021 down 60.5% 26th